New York, NY / May 22, 2014 / Cocrystal Pharma, Inc. (OTCBB: COCP) today published a new blog post on The Chairman's Blog, written by the Company's Chairman and CEO, Dr. Gary Wilcox. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
In his inaugural blog post, Dr. Wilcox reflects on the need to develop treatments for viral diseases. He writes, "With few exceptions, we do not currently have effective treatments for viral diseases...Cocrystal Pharma intends to change the battle against viral infections." Read the full blog post from Dr. Gary Wilcox on TheChairmansBlog.com (http://www.thechairmansblog.com/cocrystal-pharma/gary-wilcox/picture-immune-system-directed-human-intelligence/).
About Cocrystal Pharma, Inc.
We are a biopharma company that seeks to develop novel technologies and approaches to
create first-in-class and best-in-class broad-spectrum antiviral therapeutics for the treatment and prophylaxis of viral diseases in humans. www.cocrystalpharma.com
TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com